{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:12:37Z","timestamp":1792595557400,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41390-019-0614-2","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:06:25Z","timestamp":1571825185000},"page":"745-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A clinical score to guide in decision making for monogenic type I IFNopathies"],"prefix":"10.1038","volume":"87","author":[{"given":"Hafize Emine","family":"S\u00f6nmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"Karaaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana A.","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi Deniz","family":"Batu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"S\u00f6zeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Karaguzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Cagdas Ayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Tezcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela","family":"Goldbach-Mansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott, M. F. et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133\u2013144 (1999).","journal-title":"Cell"},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","volume":"1238","author":"YJ Crow","year":"2011","unstructured":"Crow, Y. J. & Type, I. IFNopathies: a novel set of inborn errors of immunity. Ann. NY Acad. Sci. 1238, 91\u201398 (2011).","journal-title":"Ann. NY Acad. Sci."},{"key":"614_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","volume":"33","author":"AA de Jesus","year":"2015","unstructured":"de Jesus, A. A., Canna, S. W., Liu, Y. & Goldbach-Mansky, R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu. Rev. Immunol. 33, 823\u2013874 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"614_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.coi.2017.09.003","volume":"49","author":"S Kretschmer","year":"2017","unstructured":"Kretschmer, S., Lee-Kirsch, M. A. & Type, I. IFN-mediated autoinflammation and autoimmunity. Curr. Opin. Immunol. 49, 96\u2013102 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00109-016-1465-5","volume":"94","author":"H Kim","year":"2016","unstructured":"Kim, H., Sanchez, G. A. & Goldbach-Mansky, R. Insights from Mendelian IFNopathies: comparison of CANDLE, SAVI with AGS, monogenic lupus. J. Mol. Med. (Berl.) 94, 1111\u20131127 (2016).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00281-015-0493-5","volume":"37","author":"SW Canna","year":"2015","unstructured":"Canna, S. W. & Goldbach-Mansky, R. New monogenic autoinflammatory diseases-a clinical overview. Semin. Immunopathol. 37, 387\u2013394 (2015).","journal-title":"Semin. Immunopathol."},{"key":"614_CR7","doi-asserted-by":"crossref","unstructured":"de Jesus, A. A. et al. Novel proteasome assembly chaperone mutations in PSMG2\/PAC2 cause the autoinflammatory IFNopathy CANDLE\/PRAAS4. J. Allergy Clin. Immunol. 143, 1939.e1938\u20131943.e1938 (2019).","DOI":"10.1016\/j.jaci.2018.12.1012"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10875-016-0359-1","volume":"37","author":"GI Rice","year":"2017","unstructured":"Rice, G. I. et al. Assessment of type I IFN signaling in pediatric inflammatory disease. J. Clin. Immunol. 37, 123\u2013132 (2017).","journal-title":"J. Clin. Immunol."},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/jir.2017.0127","volume":"38","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. Development of a validated IFN score using NanoString technology. J. IFN Cytokine Res. 38, 171\u2013185 (2018).","journal-title":"J. IFN Cytokine Res."},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jmedgenet-2013-102038","volume":"51","author":"JH Livingston","year":"2014","unstructured":"Livingston, J. H. et al. A type I IFN score identifies bilateral striatal necrosis due to mutations in ADAR1. J. Med. Genet. 51, 76\u201382 (2014).","journal-title":"J. Med. Genet."},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12115","volume":"175","author":"YJ Crow","year":"2014","unstructured":"Crow, Y. J., Vanderver, A., Orcesi, S., Kuijpers, T. W. & Rice, G. I. Therapies in Aicardi-Goutieres syndrome. Clin. Exp. Immunol. 175, 1\u20138 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.2933","volume":"46","author":"GI Rice","year":"2014","unstructured":"Rice, G. I. et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I IFN signaling. Nat. Genet. 46, 503\u2013509 (2014).","journal-title":"Nat. Genet."},{"key":"614_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20151529","volume":"213","author":"ME Meuwissen","year":"2016","unstructured":"Meuwissen, M. E. et al. Human USP18 deficiency underlies type 1 IFNopathy leading to severe pseudo-TORCH syndrome. J. Exp. Med. 213, 1163\u20131174 (2016).","journal-title":"J. Exp. Med."},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/s-0036-1592307","volume":"47","author":"JH Livingston","year":"2016","unstructured":"Livingston, J. H. & Crow, Y. J. Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutieres syndrome and beyond. Neuropediatrics 47, 355\u2013360 (2016).","journal-title":"Neuropediatrics"},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrrheum.2015.60","volume":"11","author":"TS van Kempen","year":"2015","unstructured":"van Kempen, T. S., Wenink, M. H., Leijten, E. F., Radstake, T. R. & Boes, M. Perception of self: distinguishing autoimmunity from autoinflammation. Nat. Rev. Rheumatol. 11, 483\u2013492 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"614_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00281-015-0500-x","volume":"37","author":"MA Lee-Kirsch","year":"2015","unstructured":"Lee-Kirsch, M. A., Wolf, C., Kretschmer, S., Roers, A. & Type, I. IFNopathies-an expanding disease spectrum of immunodysregulation. Semin. Immunopathol. 37, 349\u2013357 (2015).","journal-title":"Semin. Immunopathol."},{"key":"614_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaad.2015.10.007","volume":"74","author":"J Chia","year":"2016","unstructured":"Chia, J. et al. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy. J. Am. Acad. Dermatol. 74, 186\u2013189 (2016).","journal-title":"J. Am. Acad. Dermatol."},{"key":"614_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00109-016-1467-3","volume":"94","author":"MA Lee-Kirsch","year":"2016","unstructured":"Lee-Kirsch, M. A., Gunther, C. & Roers, A. Nucleic acid-mediated autoinflammation and autoimmunity-type I IFNopathies. J. Mol. Med. 94, 1081\u20131084 (2016).","journal-title":"J. Mol. Med."},{"key":"614_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jclinpath-2016-203810","volume":"70","author":"S Pathak","year":"2017","unstructured":"Pathak, S., McDermott, M. F. & Savic, S. Autoinflammatory diseases: update on classification diagnosis and management. J. Clin. Pathol. 70, 1\u20138 (2017).","journal-title":"J. Clin. Pathol."},{"key":"614_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","volume":"8","author":"A Torrelo","year":"2017","unstructured":"Torrelo, A. CANDLE syndrome as a paradigm of proteasome-related autoinflammation. Front. Immunol. 8, 927 (2017).","journal-title":"Front. Immunol."},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","volume":"32","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. Type I IFNopathies: mendelian type I IFN up-regulation. Curr. Opin. Immunol. 32, 7\u201312 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"614_CR22","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamadermatol.2015.0251","volume":"151","author":"J Munoz","year":"2015","unstructured":"Munoz, J. et al. Stimulator of IFN genes-associated vasculopathy with onset in infancy: a mimic of childhood granulomatosis with polyangiitis. JAMA Dermatol. 151, 872\u2013877 (2015).","journal-title":"JAMA Dermatol."},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-med-050715-104506","volume":"68","author":"MA Lee-Kirsch","year":"2017","unstructured":"Lee-Kirsch, M. A. The type I IFNopathies. Annu. Rev. Med. 68, 297\u2013315 (2017).","journal-title":"Annu. Rev. Med."},{"key":"614_CR24","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero, M. P., Crow, Y. J. & Type, I. IFN-mediated monogenic autoinflammation: The type I IFNopathies, a conceptual overview. J. Exp. Med. 213, 2527\u20132538 (2016).","journal-title":"J. Exp. Med."},{"key":"614_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","volume":"517","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Human intracellular ISG15 prevents IFN-alpha\/beta over-amplification and auto-inflammation. Nature 517, 89\u201393 (2015).","journal-title":"Nature"},{"key":"614_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. & Manel, N. Aicardi-Goutieres syndrome and the type I IFNopathies. Nat. Rev. Immunol. 15, 429\u2013440 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"614_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.autrev.2015.08.002","volume":"14","author":"C Picard","year":"2015","unstructured":"Picard, C. et al. Inherited anomalies of innate immune receptors in pediatric-onset inflammatory diseases. Autoimmun. Rev. 14, 1147\u20131153 (2015).","journal-title":"Autoimmun. Rev."},{"key":"614_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.annder.2015.06.018","volume":"142","author":"J Munoz","year":"2015","unstructured":"Munoz, J. et al. IFNopathies. Ann. Dermatol Venereol. 142, 653\u2013663 (2015).","journal-title":"Ann. Dermatol Venereol."},{"key":"614_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cytogfr.2016.03.005","volume":"29","author":"I Buers","year":"2016","unstructured":"Buers, I., Nitschke, Y. & Rutsch, F. Novel IFNopathies associated with mutations in RIG-I like receptors. Cytokine Growth Factor Rev. 29, 101\u2013107 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"614_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","volume":"14","author":"S Volpi","year":"2016","unstructured":"Volpi, S. et al. IFNopathies in pediatric rheumatology. Pediatr. Rheumatol. Online J. 14, 35 (2016).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"614_CR31","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri, M. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 64, 2677\u20132686 (2012).","journal-title":"Arthritis Rheum."},{"key":"614_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344\u2013347 (1975).","journal-title":"N. Engl. J. Med."},{"key":"614_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292, 403\u2013407 (1975).","journal-title":"N. Engl. J. Med."},{"key":"614_CR34","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty, R. E. et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 31, 390\u2013392 (2004).","journal-title":"J. Rheumatol."},{"key":"614_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders, F. et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann. Rheum. Dis. 76, 329\u2013340 (2017). d.","journal-title":"Ann. Rheum. Dis."},{"key":"614_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/cpt.936","volume":"104","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. Pharmacokinetics, pharmacodynamics, and proposed dosing of the oral JAK1 and JAK2 inhibitor baricitinib in pediatric and young adult CANDLE and SAVI patients. Clin. Pharm. Ther. 104, 364\u2013373 (2018).","journal-title":"Clin. Pharm. Ther."},{"key":"614_CR37","unstructured":"Lamot, L., Niemietz, I. & Brown, K. L. Methods for type I interferon detection and their relevance for clinical utility and improved understanding of rheumatic diseases. Clin. Exp. Rheumatol (In Press, 2019)"},{"key":"614_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507\u2013518 (2014).","journal-title":"N. Engl. J. Med."},{"key":"614_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41590-018-0287-8","volume":"20","author":"S Srikanth","year":"2019","unstructured":"Srikanth, S. et al. The Ca(2+) sensor STIM1 regulates the type I IFN response by retaining the signaling adaptor STING at the endoplasmic reticulum. Nat. Immunol. 20, 152\u2013162 (2019).","journal-title":"Nat. Immunol."},{"key":"614_CR40","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","volume":"128","author":"GAM Sanchez","year":"2018","unstructured":"Sanchez, G. A. M. et al. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory IFNopathies. J. Clin. Invest. 128, 3041\u20133052 (2018).","journal-title":"J. Clin. Invest."},{"key":"614_CR41","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jaci.2015.08.051","volume":"137","author":"DA Parry","year":"2016","unstructured":"Parry, D. A. et al. A homozygous STIM1 mutation impairs store-operated calcium entry and natural killer cell effector function without clinical immunodeficiency. J. Allergy Clin. Immunol. 137, 955\u2013957 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"614_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.0000000000004921","volume":"90","author":"K Kothur","year":"2018","unstructured":"Kothur, K. et al. An open-label trial of JAK 1\/2 blockade in progressive IFIH1-associated neuroinflammation. Neurology 90, 289\u2013291 (2018).","journal-title":"Neurology"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0614-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:22Z","timestamp":1684618102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0614-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0614-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"25 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}